exclude sleep apnea from the list of chronic health issues that may be included in these programs. In the United States, nearly 30 million adults are affected by sleep apnea. This condition occurs when the upper airway repeatedly collapses during sleep, resulting in snoring and daytime sleepiness.
Current treatments for sleep apnea include CPAP therapy, where patients wear a mask that provides mild levels of air pressure that help keep their throats open.
Some animal studies have suggested that the synthetic marijuana extract, dronabinol, could improve respiratory stability. Follow-up studies involving people have investigated the use of this drug as a new treatment option for those with sleep apnea.
But the sleep academy pointed out that dronabinol is not yet approved by the U.S. Food and Drug Administration for the treatment of sleep apnea.
The long-term safety and effectiveness of the drug and various ways people can take the drug, such as vaping and liquid formulations, are unknown. Medical marijuana may also cause daytime sleepiness and other side effects, which may make driving dangerous, the sleep academy added.
“Until there is sufficient scientific evidence of safety and efficacy, neither